Literature DB >> 11392679

A near-fatal hypersensitivity reaction to abacavir: case report and literature review.

M Shapiro1, K M Ward, J J Stern.   

Abstract

A near-fatal hypersensitivity reaction to abacavir developed in a 62-year-old HIV-seropositive man who had been sensitized 17 months before presentation. Six days after he was rechallenged, acute respiratory distress developed, requiring mechanical ventilation for 2 weeks. Four days after extubation, he was again rechallenged. Hours later, the patient experienced anaphylactic shock, requiring mechanical ventilation for 3 weeks, aggressive volume resuscitation, and vasopressor support. Recovery was complicated by acute tubular necrosis, digital necrosis, and a GI bleed. This report reviews the mechanisms of action, efficacy, and adverse reactions of abacavir and illustrates the danger of serially rechallenging patients with this agent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392679

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  13 in total

1.  Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Authors:  Timothy R Sterling; Ruth N Moro; Andrey S Borisov; Elizabeth Phillips; Gillian Shepherd; Newton Franklin Adkinson; Stephen Weis; Christine Ho; Margarita Elsa Villarino
Journal:  Clin Infect Dis       Date:  2015-04-22       Impact factor: 9.079

Review 2.  Successful translation of pharmacogenetics into the clinic: the abacavir example.

Authors:  Elizabeth Phillips; Simon Mallal
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 3.  Genotyping for severe drug hypersensitivity.

Authors:  Eric Karlin; Elizabeth Phillips
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

Review 4.  Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.

Authors:  Marina Núñez; Vincent Soriano
Journal:  Drug Saf       Date:  2005       Impact factor: 5.228

5.  HLA-B*5701 testing to predict abacavir hypersensitivity.

Authors:  Joseph D Ma; Kelly C Lee; Grace M Kuo
Journal:  PLoS Curr       Date:  2010-12-07

6.  HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  Int J Hepatol       Date:  2012-03-11

Review 7.  HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.

Authors:  Chi-Yuan Cheng; Shih-Chi Su; Chi-Hua Chen; Wei-Li Chen; Shin-Tarng Deng; Wen-Hung Chung
Journal:  J Immunol Res       Date:  2014-05-08       Impact factor: 4.818

8.  Comparison of methods for in-house screening of HLA-B*57:01 to prevent abacavir hypersensitivity in HIV-1 care.

Authors:  Ward De Spiegelaere; Jan Philippé; Karen Vervisch; Chris Verhofstede; Eva Malatinkova; Maja Kiselinova; Wim Trypsteen; Pawel Bonczkowski; Dirk Vogelaers; Steven Callens; Jean Ruelle; Kabamba Kabeya; Stephane De Wit; Petra Van Acker; Vicky Van Sandt; Marie-Paule Emonds; Paul Coucke; Erica Sermijn; Linos Vandekerckhove
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 9.  Pharmacogenetics of drug hypersensitivity.

Authors:  Elizabeth J Phillips; Simon A Mallal
Journal:  Pharmacogenomics       Date:  2010-07       Impact factor: 2.533

Review 10.  Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Authors:  Katie D White; Wen-Hung Chung; Shuen-Iu Hung; Simon Mallal; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.